With the advancement of personalized cancer immunotherapies, new tools are needed to identify tumor antigens and evaluate T-cell responses in model systems, specifically those that exhibit clinically relevant tumor progression. Key transgenic mouse models of breast cancer are generated and maintained on the FVB genetic background, and one such model is the mouse mammary tumor virus-polyomavirus middle T antigen (MMTV-PyMT) mouse-an immunocompetent transgenic mouse that exhibits spontaneous mammary tumor development and metastasis with high penetrance. Backcrossing the MMTV-PyMT mouse from the FVB strain onto a C57BL/6 genetic background, in order to leverage well-developed C57BL/6 immunologic tools, results in delayed tumor development and ...
Computational prediction of the peptides presented on MHC class I proteins is an important tool for ...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
T cells recognize peptides presented by major histocompatibility complex (MHC) proteins on cell surf...
Cancer immunotherapy continues to make headway as a treatment for advanced stage tumors, revealing a...
Breast cancer is readily treatable at early stages; however few if any treatments exist for patients...
Breast cancer is readily treatable at early stages; however few if any treatments exist for patients...
The major histocompatibility complex (MHC) class II-asso-ciated Invariant chain (Ii) is present in p...
HER-2/neu oncoprotein is overexpressed in a variety of human tumors and is associated with aggressiv...
Cytotoxic T cells are of central importance in the immune system's response to disease. They recogni...
Activation of tumor-reactive T lymphocytes is a promising approach for the treatment of patients wit...
Activation of tumor-reactive T lymphocytes is a promising approach for the treatment of patients wit...
A key event in the generation of a cellular response against malicious organisms through the endocyt...
Background: Neoplastic transformation is a multistep process in which distinct gene products of spec...
Tumor Associated Antigens (TAAs) may suffer from an immunological tolerance due to expression on nor...
Major histocompatibility complex (MHC) class II antigen presentation is a key component in eliciting...
Computational prediction of the peptides presented on MHC class I proteins is an important tool for ...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
T cells recognize peptides presented by major histocompatibility complex (MHC) proteins on cell surf...
Cancer immunotherapy continues to make headway as a treatment for advanced stage tumors, revealing a...
Breast cancer is readily treatable at early stages; however few if any treatments exist for patients...
Breast cancer is readily treatable at early stages; however few if any treatments exist for patients...
The major histocompatibility complex (MHC) class II-asso-ciated Invariant chain (Ii) is present in p...
HER-2/neu oncoprotein is overexpressed in a variety of human tumors and is associated with aggressiv...
Cytotoxic T cells are of central importance in the immune system's response to disease. They recogni...
Activation of tumor-reactive T lymphocytes is a promising approach for the treatment of patients wit...
Activation of tumor-reactive T lymphocytes is a promising approach for the treatment of patients wit...
A key event in the generation of a cellular response against malicious organisms through the endocyt...
Background: Neoplastic transformation is a multistep process in which distinct gene products of spec...
Tumor Associated Antigens (TAAs) may suffer from an immunological tolerance due to expression on nor...
Major histocompatibility complex (MHC) class II antigen presentation is a key component in eliciting...
Computational prediction of the peptides presented on MHC class I proteins is an important tool for ...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
T cells recognize peptides presented by major histocompatibility complex (MHC) proteins on cell surf...